SELF-REPORTED GENERAL HEALTH AND OUTCOMES IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: EXPERIENCES FROM THE GLOBAL STABILITY TRIAL

R. A. H. Stewart,Emil Hagström,Claes Held,Paul W. Armstrong,Philip Aylward,Christopher Cannon,Wolfgang Koenig,Jose Lopez-Sendon,Emile Mohler,Nermin Hadziosmanovic,Susan Krug-Gourley,Saulat Siddique,Philippe Gabriel Steg,Harvey D. White,Lars Wallentin

SELF-REPORTED GENERAL HEALTH AND OUTCOMES IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: EXPERIENCES FROM THE GLOBAL STABILITY TRIAL

2016

R. A. H. Stewart
Emil Hagström
Claes Held
Paul W. Armstrong
Philip Aylward
Christopher Cannon
Wolfgang Koenig
Jose Lopez-Sendon
Emile Mohler
Nermin Hadziosmanovic
Susan Krug-Gourley
Saulat Siddique
Philippe Gabriel Steg
Harvey D. White
Lars Wallentin

General health is an important determinant of quality of life, but the prognostic significance of self-reported health by patients with stable coronary heart disease (CHD) is uncertain. The STABILITY trial randomized 15,828 patients with stable CHD to treatment with darapladib or placebo in

Keywords:

Darapladib
Heart disease
Diabetes mellitus
Placebo
Coronary artery disease
Internal medicine
Cardiology
Physical therapy
Medicine
general health
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations